Partial Splenectomy in the treatment of an adult with β thalassemia intermedia: A case report

Int J Surg Case Rep. 2017 Nov 11:41:446-449. doi: 10.1016/j.ijscr.2017.11.011. eCollection 2017.

Abstract

Introduction: Thalassemia is a common disease which treatment is often based on splenectomy. The risks associated with total splenectomy stimulated partial splenectomy as a potentially alternative therapy.

Case presentation: A 45 year-old female patient with long term follow-up for β thalassemia intermedia started to develop signs of hypersplenism and iron overload. A partial splenectomy was performed and was observed a marked hematologic improvement while preserving the desired splenic function.

Discussion: Partial splenectomy proved to provide a persistent decrease in hemolytic rate while preserving the integrity of splenic phagocytic function, presenting itself as an effective alternative to total splenectomy. After being subjected to partial splenectomy, our patient experienced a sustained control of hemolysis and showed no signs of hypersplenism or iron overload. No splenic regrowth or infectious complications were observed. The major drawbacks of partial splenectomy are the increased risk of intra- and postoperative bleeding, splenic remnant torsion and splenic regrowth.

Conclusion: Partial splenectomy is an alternative to total splenectomy for the treatment of adult β Thalassemia intermedia patients avoiding the risks associated with total splenectomy.

Keywords: Adult; Fr, serum ferritin; Hb, hemoglobin; Hct, hematocrit; Hypersplenism; MRI, magnetic resonance imaging; OPSI, overwhelming post-splenectomy infections; Partial splenectomy; Plt, platelet; Ret, reticulocytes; Tbr, total bilirubin; US, ultrasonography; β Thalassemia intermedia.